Intra Cellular Therapies News

ITCIDelisted Stock  USD 131.87  0.03  0.02%   
Under 62% of Intra Cellular's investor base is looking to short. The analysis of current outlook of investing in Intra Cellular Therapies suggests that many traders are alarmed regarding Intra Cellular's prospects. Intra Cellular's investing sentiment shows overall attitude of investors towards Intra Cellular Therapies.
  
over three months ago at thelincolnianonline.com         
Renaissance Technologies LLC Has 26.27 Million Stock Position in Intra-Cellular Therapies, Inc.
news
over three months ago at finance.yahoo.com         
Should John Hancock Multifactor Small Cap ETF Be on Your Investing Radar?
Yahoo News
over three months ago at finance.yahoo.com         
Should Schwab U.S. Small-Cap ETF Be on Your Investing Radar?
Yahoo News
over three months ago at finance.yahoo.com         
Is John Hancock Multifactor Small Cap ETF a Strong ETF Right Now?
Yahoo News
over three months ago at www.macroaxis.com         
Disposition of 52811 shares by Mark Neumann of Intracellular at 132.0 subject to Rule 16b-3
Macroaxis News
over three months ago at thelincolnianonline.com         
Cynosure Group LLC Decreases Position in Intra-Cellular Therapies, Inc.
news
over three months ago at businesswire.com         
Johnson Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience ...
businesswire News
over three months ago at finance.yahoo.com         
Johnson Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience ...
Yahoo News
over three months ago at businesswire.com         
Johnson Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience ...
businesswire News
over three months ago at gurufocus.com         
Disposition of 22727 shares by Sanjeev Narula of Intracellular subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
Johnson Johnson Closes Landmark Intra-Cellular Therapies, Inc. ...
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
Johnson Johnson Completes Acquisition of Intra-Cellular Therapies
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
Johnson Johnson Announces Completion Timeline for Intra-Cellular Therapies Acquisition
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
Johnson Johnson Announces Expected Closing Date for Intra-Cellular Acquisition
Gurufocus Stories at Macroaxis
over three months ago at businesswire.com         
Johnson Johnson Announces Expected Closing Date for Intra-Cellular Acquisition
businesswire News
There is far too much social signal, news, headlines, and media speculation about Intra Cellular that are available to investors today. This information is accessible both publicly - through Intra Cellular's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Intra-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Intra Cellular news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Intra Cellular relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Intra Cellular's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Intra Cellular alpha.

Intra Cellular Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Sanjeev Narula of 22727 shares of Intracellular subject to Rule 16b-3
02/03/2025
2
Intra-Cellular Therapies GAAP EPS of -0.16 misses by 0.04, revenue of 199.22M beats by 5.93M
02/21/2025
3
Acquisition by Mark Neumann of 18714 shares of Intracellular at 36.89 subject to Rule 16b-3
03/03/2025
4
Is Intra-Cellular Therapies, Inc. a Best Biotech Stock According to Billionaires
03/17/2025
5
Deep Track Capital, LP Acquires Significant Stake in Dianthus Therapeutics Inc
03/24/2025
6
Johnson Johnson Presents Promising Nipocalimab Data At AAN Annual Meeting
03/27/2025
7
Johnson Johnson Announces Expected Closing Date for Intra-Cellular Acquisition
04/01/2025
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Consideration for investing in Intra Stock

If you are still planning to invest in Intra Cellular Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intra Cellular's history and understand the potential risks before investing.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities